Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
207.00    1.00 (0.49%)
Bid:
205.20
Ask:
205.60
Spread: 0.40 (0.195%)
Market Cap: £4.05b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Non-Executive Director appointment

16 Dec 2021 14:00

RNS Number : 9330V
ConvaTec Group PLC
16 December 2021
 

ConvaTec Group PLC

Non-Executive Director Appointment

 

Reading, United Kingdom - 16th December 2021

 

ConvaTec Group PLC ("ConvaTec" or "the Company") is pleased to announce the appointment of Kimberly ("Kim") Lody as a Non-Executive Director of the Company with effect from 1 February 2022. Kim will join ConvaTec's Nomination and Remuneration committees on the same date.

Since 2019, Kim has been the President and Chief Executive Officer of Sonida Senior Living Corporation, one of the USA's largest owner-operators of senior housing communities. Kim has an extensive background in international, multi-cultural environments with more than 25 years of healthcare experience including alternate site healthcare services, durable medical equipment and medical devices.

From 2011-2019, Kim served firstly as President of Resound and then as SVP and President of GN Hearing, both of which are medical device divisions of the GN Group. From 2009 - 2011, Kim was Vice President of Marketing and then President of Chronic Care for the U.S. subsidiary of Coloplast. From 2004-2009, Kim was an independent consultant to the healthcare sector. Her earlier career included serving as COO of Senior Home Care; CMO of Gentiva Health Services; and VP of Managed Care Programs for Apria Healthcare.

Kim holds a bachelor's degree in Business Administration from Hiram College in Ohio and an MBA with a concentration in finance from Wake Forest University, North Carolina.

John McAdam, Chairman of ConvaTec, commented:

"I am delighted to welcome Kim to our Board. She has deep healthcare knowledge, an impressive track record and brings to the Board very relevant international, commercial and operational experience. We look forward to Kim's contribution to our Board discussions."

This announcement is made in accordance with Listing Rule 9.6.11R (1). No other information is required to be disclosed in accordance with Listing Rule 9.6.13.

Enquiries:

Analysts and Investors

Kate Postans, Vice President, Investor Relations +44(0)7826 447 807

ir@convatec.com

Media

Buchanan: Chris Lane +44(0)207 466 5000

ConvaTec Group PLC's LEI code is 213800LS272L4FIDOH92

About ConvaTec Group PLCConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKABQNBDDFBD
Date   Source Headline
28th May 202611:00 amRNSHolding(s) in Company
27th May 202611:00 amRNSDirector/PDMR Shareholding
26th May 202611:00 amRNSHolding(s) in Company
21st May 20263:30 pmRNSResults of AGM
21st May 20267:00 amRNSAGM trading update for four months ended 30 April
13th Apr 202612:00 pmRNSProfessor Constantin Coussios steps down
9th Apr 20267:00 amRNSCapital Markets Day
17th Mar 20261:00 pmRNSNotice of AGM
17th Mar 202611:00 amRNSDirector/PDMR Shareholding
12th Mar 20262:30 pmRNSDirector/PDMR Shareholding
10th Mar 20261:00 pmRNSPublication of Annual Report
24th Feb 20267:00 amRNSConvatec FY25 Results
6th Feb 202611:00 amRNSHolding(s) in Company
2nd Jan 202611:00 amRNSTotal Voting Rights
19th Dec 202512:00 pmRNSHolding(s) in Company
19th Dec 202512:00 pmRNSHolding(s) in Company
17th Dec 20253:00 pmRNSHolding(s) in Company
10th Dec 20253:00 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 202512:00 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202511:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 202511:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20255:30 pmRNSHolding(s) in Company
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20251:30 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20256:00 pmRNSConvaTec Group
18th Nov 20257:00 amRNSPRICED SECONDARY OFFERING IN CONVATEC GROUP PLC
17th Nov 20254:57 pmRNSPROPOSED SECONDARY OFFERING IN CONVATEC GROUP PLC
14th Nov 20253:00 pmRNSHolding(s) in Company
13th Nov 20257:05 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTrading update for 10 months ended 31 October 2025
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:05 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSCEO and CFO appointments
5th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.